Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
Clinical trial NCT03395873 · TERMINATED
Trial details
- NCT number
- NCT03395873
- Sponsor
- Milton S. Hershey Medical Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2019-05-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.